V
主页
Targeting the insulin-like growth factor-1 receptor in
发布人
打开封面
下载高清视频
观看高清视频
视频下载器
Muramyl Dipeptide-Based Postbiotics Mitigate Obesity-Induced Insulin Resistance
沙库巴曲缬沙坦降低射血分数保留型心衰患者收缩压
Insulin-like Growth Factors and Kidney Disease
Targeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistance
autoantibodies targeting nephrin in MCD supports a novel autoimmune etiology
lncRNA NR_038323 Suppresses Renal Fibrosis in Diabetic Nephropathy by Targeting
Long-Term High-Fat Diet Decreases Renal Insulin-Degrading Enzyme Expression and
LncRNA SOX2OT通过Akt/mTOR介导的自噬减轻糖尿病肾病肾小球系膜细胞增殖和纤维化
Activation of intestinal hypoxia-inducible factor 2α during obesity contributes
SGLT2抑制剂对于肾脏的影响
Targeting POLE2 Creates a Novel Vulnerability in Renal Cell Carcinoma
诺欣妥治疗高血压的长期有效性和安全性
IgG4糖基化可以通过凝集素补体途径加重MN
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
利妥昔单抗或环磷酰胺治疗膜性肾病的随机对照试验
Concurrent IgA Nephropathy and Membranous Nephropathy
Fusobacterium nucleatum--rheumatoid arthritis
IgAN IgAV- Kdigo Guideline
Altered glycosylation of IgG4 promotes lectin complement pathway activation MN
血透患者肠道紊乱与死亡率的关系
urinary exosomal hsa-circ-0001250
F.nucleatum Promotes Chemoresistance to CRC by Modulating autophagy
Akt / FoxO3a途径在TGF-β1介导的肾小球系膜细胞功能障碍:一种与糖尿病肾病相关的新机制
Rituximab in IMN
Race ,genetic ancestry,and estimating kidney function in CKD
Toxic occuopational exposures and Membranous nephropathy
2种免疫抑制剂对IgA的影响
一篇包含了ESRD的肠道菌群、代谢组学、动物实验的文献
PLA2R autoantibodies and clinical outcome in patients with PMN
Expansion of Escherichia-Shigella in Gut is Associate with IgAN
直接肾素抑制剂在非糖尿病肾病患者中的作用
B and T cell in patients with IMN may predict a response to rituximab
Canagliflozin reduces inflammation and fibrosis biomarkers
KN is linked to disease-activity associated expnsions, immunity to gut commensal
Assassination of HLA Typing and Alloimmunity With Posttransplantation MN
DN中肌酐排泄率与死亡率的关系
黄连素和益生菌对2型糖尿病肠道微生物的影响(前期研究)
F . nucleatum lncRNA ENO1- IT1 glycolysis colorectal cancer
IgAN强化支持治疗+免疫抑制治疗
Metabolic Effects of Dapagliflozin with Type 1 Diabetes